Items where Author is "Kanavos, P."

Zaitceva, V, Tan, I, Mills, M. and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) HPR253 Drug development and launch timeline analysis across 6 high-income countries: from pivotal trial to HTA. Value in Health, 27 (12, Supplement). S323 - S323. ISSN 1098-3015

Eaves, K., Lin, R., Alani, A. H. ORCID: 0000-0001-6318-3017, Mills, M. and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) HTA117 Sentiment analysis of clinical evaluations in HTA: evidence from Canada, England, Scotland, Sweden, France, and Germany. Value in Health, 27 (12, Supplement). S376 - S376. ISSN 1098-3015

Civitelli, D. ORCID: 0009-0002-9398-8857, Politopoulou, K., Mills, Mackenzie and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) HTA18 First to launch, first to falter?: an investigation into the clinical benefits and HTA outcomes for first-in-class drugs. Value in Health, 27 (12, Supplement). S356 - S356. ISSN 1098-3015

Alani, A. H. ORCID: 0000-0001-6318-3017, Eaves, K., Mills, Mackenzie and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) HTA246 Improving access to innovative therapies for rare bleeding disorders: evidence from high income countries. Value in Health, 27 (12). S402 - S403. ISSN 1098-3015

Tolkmitt, F., Chavez, D., Mills, M. and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) HTA354 Determinants of added benefit ratings in Germany: an econometric analysis of assessments from the Federal Joint Committee between 2012 and 2024. Value in Health, 27 (12 Supplement). S425 - S425. ISSN 1098-3015

Lin, R., Eaves, K., Mills, M. and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) HTA64 Leveraging machine learning for predicting health technology assessment outcomes. Value in Health, 27 (12, Supplement). S365 - S365. ISSN 1098-3015

Chavez, D., Tolkmitt, F., Mills, M. and Kanavos, P. ORCID: 0000-0001-9518-3089 (2024) PT7 Reassessment dynamics of orphan drugs in Germany's benefit assessment process. Value in Health, 27 (12, Supplement). S323 - S323. ISSN 1098-3015